[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-351659-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-351659-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","nanoparticles-an-emerging-hope-in-cancer-therapy","Nanoparticles - An Emerging Hope in Cancer Therapy","","Cancer remains a major global health challenge driven by abnormal cell growth and metastasis. Conventional therapies often suffer from non-specific toxicity to healthy tissue, motivating targeted strategies. Nanotechnology uses nanoparticles for more precise drug delivery to tumor sites with reduced off-target effects. Nanometer-scale particles improve binding to cancer membranes, the tumor microenvironment, or nuclear receptors, raising local therapeutic concentrations. Nanoparticles are synthesized by physical, chemical, or biological routes and reviewed across breast, prostate, and lung cancer applications and clinical directions.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/nanoparticles-an-emerging-hope-in-cancer-therapy/351659/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/nanoparticles-an-emerging-hope-in-cancer-therapy/351659.png","ImageObject",300,407,{"name":42,"@type":43},"Cipher","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-11","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why are conventional cancer therapies considered limited?","Question",{"text":63,"@type":64},"They often rely on non-specific toxicity that can harm healthy cells. This motivates targeted delivery approaches to improve therapeutic selectivity.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How do nanoparticles help improve cancer treatment targeting?",{"text":68,"@type":64},"Nanoparticles enable more precise drug delivery to tumor sites while minimizing off-target effects. They can enhance local concentrations by binding to cancer membranes, the tumor microenvironment, or nuclear receptors.",{"name":70,"@type":61,"acceptedAnswer":71},"What key delivery mechanisms are highlighted for nanoparticles?",{"text":72,"@type":64},"The review discusses the Enhanced Permeability and Retention (EPR) effect and Active Transport and Retention (ATR) as major nanoparticle delivery mechanisms.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},351659,1790740856,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},687208528416,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","Review  \nNanoparticles: An Emerging Hope in Cancer Therapy  \nShahid Sher 1, *, Rosny Jean 2 and Zaman Khan 3  \nAcademic Editor: Neeraj Chauhan  \nReceived: 17 March 2026  \nRevised: 20 April 2026  \nAccepted: 22 April 2026  \nPublished: 24 April 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 Department of Microbiology and Cell Science, University of Florida, Gainesville, FL 32611, USA  \n2 School of the Environment, Florida Agricultural and Mechanical University, Tallahassee, FL 32307, USA; [rosny.jean@famu.edu](rosny.jean@famu.edu)  \n3 Department of Biological and Environmental Sciences, Faculty of Sciences, Emerson University Multan, Multan 60760, Pakistan; [hmzamankhan@gmail.com](hmzamankhan@gmail.com)  \n* [Correspondence: shahid.sher@ufl.edu](Correspondence: shahid.sher@ufl.edu)  \nAbstract  \nCancer remains a major global health challenge, characterized by abnormal cell growth and metastasis. Current limitations of conventional therapies, particularly non-specific toxicity harming healthy cells, highlight the need for more targeted approaches. Nanotechnology offers a revolutionary solution, utilizing nanoparticles (NPs) for precise drug delivery to tumor sites while minimizing off-target effects. These nanometer-scale particles enable superior binding to cancer cell membranes, the tumor microenvironment, or nuclear receptors, facilitating significantly higher local concentrations of therapeutic agents. NPs, synthesized via physical, chemical, or biological methods, are categorized as organic (organic material-based) or inorganic (metallic particle-based) . Key delivery mechanisms include the Enhanced Permeability and Retention (EPR) effect and Active Transport and Retention (ATR) . This review specifically examines NP applications for the most prevalent cancers in the US (2025): breast, prostate, and lung. Gold and magnetic NPs show significant promise for early breast cancer detection. For lung cancer, polymeric NPs like PCL, PLA, and PLGA are effective carriers for peptides, proteins, and nucleic acids. BIND-014, a docetaxel-loaded NP formulation, represents an emerging strategy for prostate cancer. Clinically established examples include liposomal doxorubicin and albumin-bound paclitaxel. We comprehensively discuss the synthesis methods, delivery mechanisms, and the current landscape of NPs in research and clinical trials for these cancers. This analysis underscores the potential of nanotechnology to provide more effective and targeted therapeutic options for cancer patients in the future. A distinctive feature of this review is its comparative cancer-specific analysis of NP platforms in breast, prostate, and lung cancers. Unlike previous generalized reviews, this work integrates synthesis strategies, delivery mechanisms, translational challenges, and clinically relevant formulations to provide a bench-to-bedside perspective on the future of nanomedicine in oncology.  \nKeywords: nanoparticles; synthesis; cancer; drugs; delivery mechanisms; therapy  \n1. Introduction  \nCancer is a major global health problem and represents one of the greatest challenges of the 21st century [1] . It is characterized by uncontrolled cell division driven by alterationsin genetic, epigenetic, and transcriptional regulation [2] . Cancer development involves dynamic changes in the genome, leading to tumor formation. Tumors can be broadly classified as benign or malignant; benign tumors remain localized, whereas malignant tumors are invasive and can spread to distant organs via the bloodstream and lymphatic  \nsystem, a process known as metastasis [3,4] . Cancer cells differ from normal cells due to deregulated signaling pathways, including those controlling the cell cycle, apoptosis, DNA repair, and redox balance [5] . The development of cancer typically progresses through three stages:","cbCaivvQC0bP5A3T","https://ap.wps.com/l/cbCaivvQC0bP5A3T","pdf",1524392,25,"English","# Abstract\n# Keywords\n# 1. Introduction","[{\"question\":\"Why are conventional cancer therapies considered limited?\",\"answer\":\"They often rely on non-specific toxicity that can harm healthy cells. This motivates targeted delivery approaches to improve therapeutic selectivity.\"},{\"question\":\"How do nanoparticles help improve cancer treatment targeting?\",\"answer\":\"Nanoparticles enable more precise drug delivery to tumor sites while minimizing off-target effects. They can enhance local concentrations by binding to cancer membranes, the tumor microenvironment, or nuclear receptors.\"},{\"question\":\"What key delivery mechanisms are highlighted for nanoparticles?\",\"answer\":\"The review discusses the Enhanced Permeability and Retention (EPR) effect and Active Transport and Retention (ATR) as major nanoparticle delivery mechanisms.\"}]","Nanoparticles - An Emerging Hope in Cancer Therapy | PDF",1790095157,63,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0b3d98a959ae4cf2b84e8221b5b06cc4.webp",983,1390,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/204a2bffcfd6b48cb2fa39c3dafb9d77.webp",982,1388,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0356f6784e02b692793df5fbffb0c886.webp",981,1387,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a1bef63c9224368e90e65377c89a5352.webp",980,1385]